Lumenis has announced a new partnership with Bosley. Bosley is now the first national hair restoration medical practice in the U.S. to offer FoLix, the only FDA-cleared fractional laser for hair loss treatment. Recently cleared by the FDA, FoLix is the first and only fractional laser designed to provide safe, effective, and natural hair loss treatment for both women and men in the United States.
Bosley initially started offering FoLix at its Beverly Hills location beginning September 2024 and plans to roll out the service at its other locations across the country over time. This partnership initiates a new era in hair loss treatment by introducing the first FDA-cleared fractional laser solution for hair loss to U.S. customers for the first time, potentially benefiting more than 80 million people affected by hair loss across the country. The partnership also highlights Bosley's dedication to supporting customers in their fight against hair loss, reinforcing its position as one of the world's most trusted and experienced hair restoration experts. "Staying at the forefront of innovations and excellence, we are always looking for the latest and most effective advancements to support our customers in their hair restoration journey," says Rob Spurrell, CEO and President of Bosley. "FoLix is a strong and perfect fit for our expanding range of solutions, as it offers a non-surgical, in-office approach with minimal discomfort, showing promising results in several monthly sessions."
Following the FDA clearance granted earlier this year, Lumenis launched FoLix, a groundbreaking innovation in hair loss treatment and the first of its kind. Developed with Lumenis' proprietary technology, FoLix offers a non-invasive, effective, simple, and safe solution that uses a unique approach to deliver precise pulses of laser light that leverage the body's natural processes to stimulate hair follicles. FoLix is anticipated to attract considerable interest from people impacted by hair loss, as it offers results through 4-6 monthly sessions with no chemicals, needles, anesthesia, or downtime.
For more information about FoLix, visit Lumenis.com/FoLix